Benitec's Hepatitis C Drug Resurrected by Startup Company and Industry Veterans

/Home/Biologics Delivery - Protein Synthesis/RNA - Protein Synthesis/RNAi - Protein Synthesis

Benitec's Hepatitis C Drug Resurrected by Startup Company and Industry Veterans
By Doug Macron
October 12, 2006
RNAi News
Tacere Therapeutics, whose name is Italian for ?to be silent,? was founded in July by two Benitec alums including former CEO Sara Cunningham Hall and ex-CFO Mike Catelani. The company plans to pursue both RNAi and small molecule therapeutics for hepatitis C.
Paid subscription is required to view article.